bf/NASDAQ:CDLX_icon.png

NASDAQ:CDLX

Cardlytics, Inc.

  • Stock

USD

Last Close

3.80

22/11 21:00

Market Cap

394.17M

Beta: 1.73

Volume Today

532.80K

Avg: 2.29M

PE Ratio

−0.69

PFCF: −9.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
77.63M
-
112.82M
45.32%
130.37M
15.55%
150.68M
15.59%
210.43M
39.65%
186.89M
11.19%
267.12M
42.93%
298.54M
11.76%
309.20M
3.57%
cost of revenue
52.49M
-
72.41M
37.94%
80.26M
10.84%
96.00M
19.62%
130.97M
36.43%
123.62M
5.62%
163.78M
32.49%
185.91M
13.51%
177.04M
4.77%
gross profit
25.14M
-
40.41M
60.74%
50.11M
24.00%
54.68M
9.13%
79.46M
45.31%
63.27M
20.37%
103.34M
63.32%
112.63M
8.99%
132.17M
17.34%
selling and marketing expenses
32.78M
-
31.26M
4.65%
31.93M
2.13%
41.88M
31.17%
43.83M
4.66%
45.31M
3.37%
66.00M
45.66%
74.75M
13.26%
44.80M
40.06%
general and administrative expenses
18.20M
-
21.36M
17.35%
20.10M
5.88%
34.23M
70.29%
36.72M
7.28%
46.53M
26.72%
66.22M
42.31%
81.45M
22.99%
71.43M
12.29%
selling general and administrative expenses
50.98M
-
52.62M
3.21%
52.03M
1.12%
76.11M
46.28%
80.55M
5.84%
91.84M
14.02%
132.22M
43.97%
156.19M
18.13%
144.48M
7.50%
research and development expenses
11.60M
-
13.90M
19.80%
12.15M
12.60%
16.21M
33.42%
11.70M
27.83%
17.53M
49.86%
38.10M
117.34%
54.44M
42.86%
51.35M
5.66%
other expenses
-432K
-
-13.26M
2,969.91%
6.28M
147.34%
-2.10M
133.47%
4.54M
315.85%
7.83M
72.57%
29.87M
281.69%
37.54M
25.69%
cost and expenses
117.27M
-
143.15M
22.06%
147.46M
3.01%
191.60M
29.93%
227.75M
18.87%
240.81M
5.73%
363.97M
51.14%
434.08M
19.26%
372.87M
14.10%
operating expenses
64.78M
-
70.74M
9.20%
67.20M
4.99%
95.60M
42.25%
96.78M
1.24%
117.20M
21.09%
200.19M
70.82%
248.17M
23.97%
195.84M
21.09%
interest expense
-8.24M
-
1.38M
-
3.05M
121.35%
12.56M
312.17%
2.56M
79.65%
6.18M
141.90%
ebitda
-38.36M
-
-173K
99.55%
-13.49M
7,697.69%
-30.88M
128.87%
-12.79M
58.57%
-42.33M
230.97%
-61.20M
44.57%
-91.80M
50.00%
-34.15M
62.79%
operating income
-39.64M
-
-56.23M
41.86%
-17.10M
69.59%
-40.92M
139.29%
-17.32M
57.66%
-53.92M
211.24%
-96.85M
79.61%
-135.54M
39.94%
-63.67M
53.02%
depreciation and amortization
2.19M
-
4.22M
92.30%
3.03M
28.23%
3.28M
8.39%
4.54M
38.18%
11.59M
155.61%
35.65M
207.57%
43.74M
22.68%
29.52M
32.52%
total other income expenses net
482K
-
-39.20M
8,232.37%
5.70M
114.53%
-8.86M
255.54%
181K
102.04%
-1.50M
928.18%
-39.58M
2,540.16%
-331.17M
736.80%
-71.03M
78.55%
income before tax
-40.64M
-
-75.70M
86.26%
-19.64M
74.05%
-53.04M
170.06%
-17.14M
67.68%
-55.42M
223.27%
-136.43M
146.16%
-466.71M
242.09%
-134.70M
71.14%
income tax expense
-16K
-
32.11M
200,762.50%
5.74M
82.11%
-12.13M
311.13%
548K
104.52%
3.05M
456.20%
-7.86M
358.01%
-1.45M
81.61%
134.70M
9,415.49%
net income
-40.63M
-
-75.70M
86.33%
-19.64M
74.05%
-53.04M
170.06%
-17.69M
66.65%
-58.47M
230.49%
-128.56M
119.88%
-465.26M
261.89%
-134.70M
71.05%
weighted average shs out
14.03M
-
14.03M
0%
19.52M
39.16%
19.06M
2.35%
23.75M
24.59%
27.21M
14.60%
32.20M
18.33%
33.42M
3.78%
36.49M
9.18%
weighted average shs out dil
14.03M
-
14.03M
0%
19.52M
39.16%
19.06M
2.35%
23.75M
24.59%
27.21M
14.60%
32.20M
18.33%
33.42M
3.78%
36.49M
9.18%
eps
-2.90
-
-5.40
86.21%
-1.01
81.30%
-2.78
175.25%
-0.75
73.02%
-2.15
186.67%
-3.99
85.58%
-13.92
248.87%
-3.69
73.49%
epsdiluted
-2.90
-
-5.40
86.21%
-1.01
81.30%
-2.78
175.25%
-0.75
73.02%
-2.15
186.67%
-3.99
85.58%
-13.92
248.87%
-3.69
73.49%

All numbers in USD (except ratios and percentages)